4.4 Editorial Material

The US Food and Drug Administration, the mechanism of action, and other considerations for cell-based therapy candidates

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Systematic Review on CAR-T Cell Clinical Trials Up to 2022: Academic Center Input

Valentine Wang et al.

Summary: The development of CAR-T cell clinical trials has greatly advanced in the United States and China, while Europe lags behind. Poorly developed academic and industrial collaborations, as well as regulatory and financial differences, contribute to Europe's delay. Strengthening the development and providing financial support would accelerate the process in Europe.

CANCERS (2023)

Article Public, Environmental & Occupational Health

Cell and gene therapy regulatory, pricing, and reimbursement framework: With a focus on South Korea and the EU

SungKyung Lee et al.

Summary: With the maturity of bioengineering technologies, significant investments have been made in the cell and gene therapy market, resulting in abundant clinical studies. This has led to the development of regulatory guidelines and legislative rules to regulate pharmaceutical products in this field. Pricing and reimbursement policies have also shifted towards sharing risks and expanding access to innovative therapies. This review focuses on the regulatory features of the cell and gene therapy market in South Korea and the European Union, highlighting the need for harmonization and collaboration between medical authorities.

FRONTIERS IN PUBLIC HEALTH (2023)

Article Multidisciplinary Sciences

Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells

J. Joseph Melenhorst et al.

Summary: CAR T cells redirected to target CD19 demonstrated long-lasting potential and clonal stability in two patients with chronic lymphocytic leukaemia. Highly activated CD4(+) cells emerged and dominated the CAR T cell population at later time points. These unexpected CAR T cell populations provide novel insights into anti-cancer response and long-term remission in leukaemia.

NATURE (2022)

Article Multidisciplinary Sciences

Potential solutions for manufacture of CAR T cells in cancer immunotherapy

Ulrich Blache et al.

Summary: CAR T cell therapy is effective in treating cancer, but obstacles in biology and manufacturing hinder its widespread application. New technologies are needed to enable the treatment of larger patient groups.

NATURE COMMUNICATIONS (2022)

Review Immunology

Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease

Kilian Kelly et al.

Summary: GvHD is a life-threatening complication of hematopoietic stem cell transplantation, often requiring high-dose corticosteroid treatment. MSCs show promise as a potential therapy due to their immunosuppressive and immunoregulatory effects, but their efficacy may be influenced by donor variability and manufacturing processes.

FRONTIERS IN IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring

Shamik Mascharak et al.

Summary: This study identified a dermal ENF subpopulation that activates Engrailed-1 expression through mechanical tension, promoting skin tissue regeneration. Blocking mechanotransduction signaling can stimulate ENF-mediated wound regeneration, leading to recovery of skin appendages and mechanical strength.

SCIENCE (2021)

Review Health Care Sciences & Services

Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997-2020)

Nikola A. Ivica et al.

Summary: CAR-T/TCR-T cellular immunotherapies have shown remarkable success in treating refractory B-cell malignancies. The increase in clinical trials is driven by the development of different CAR-T products, with China and the US being major innovators in the field. This industry exhibits a robust response to competitor products, with the term "bioparallels" coined to describe similar therapeutic approaches.

HEALTHCARE (2021)

Article Multidisciplinary Sciences

The bone marrow microenvironment at single-cell resolution

Anastasia N. Tikhonova et al.

NATURE (2019)

Article Multidisciplinary Sciences

Identification of a mesenchymal progenitor cell hierarchy in adipose tissue

David Merrick et al.

SCIENCE (2019)

Article Cardiac & Cardiovascular Systems

Effects of Statins on Memory, Cognition, and Brain Volume in the Elderly

Katherine Samaras et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Pharmacology & Pharmacy

The Use of Stem Cell Therapy to Reverse Opioid Tolerance

Fei Li et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)

Article Orthopedics

New MSC: MSCs as Pericytes Are Sentinels and Gatekeepers

Arnold I. Caplan

JOURNAL OF ORTHOPAEDIC RESEARCH (2017)

News Item Biotechnology & Applied Microbiology

CAR T therapies drive into new terrain

Katie Kingwell

NATURE REVIEWS DRUG DISCOVERY (2017)

Review Medicine, Research & Experimental

Global Manufacturing of CAR T Cell Therapy

Bruce L. Levine et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)

Article Multidisciplinary Sciences

Mesenchymal Stem Cells Reversed Morphine Tolerance and Opioidinduced Hyperalgesia

Zhen Hua et al.

SCIENTIFIC REPORTS (2016)

Review Oncology

Engineered T cells for cancer therapy

Carl H. June et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)

Review Cell & Tissue Engineering

Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation

Maria Ester Bernardo et al.

CELL STEM CELL (2013)

News Item Biochemistry & Molecular Biology

Japan to offer fast-track approval path for stem cell therapies

David Cyranoski

NATURE MEDICINE (2013)

Article Cell & Tissue Engineering

The MSC: An Injury Drugstore

Arnold I. Caplan et al.

CELL STEM CELL (2011)

Review Psychology

A comprehensive review of the placebo effect: Recent advances and current thought

Donald D. Price et al.

ANNUAL REVIEW OF PSYCHOLOGY (2008)

Editorial Material Cell & Tissue Engineering

All MSCs are pericytes?

Arnold I. Caplan

CELL STEM CELL (2008)

Article Cell & Tissue Engineering

A perivascular origin for mesenchymal stem cells in multiple human organs

Mihaela Crisan et al.

CELL STEM CELL (2008)

Article Biochemistry & Molecular Biology

Mesenchymal stem cells as trophic mediators

Arnold I. Caplan et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2006)

Article Pharmacology & Pharmacy

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

M Schachter

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)

Review Cell Biology

Statins: mechanism of action and effects

C Stancu et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2001)

Article Medicine, General & Internal

Risk of cardiovascular events associated with selective COX-2 inhibitors

D Mukherjee et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)

Article Medicine, General & Internal

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.

C Bombardier et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)

Article Cardiac & Cardiovascular Systems

Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins

U Rauch et al.

ATHEROSCLEROSIS (2000)